OR WAIT null SECS
On the HCPLive inflammatory bowel disease page, resources on the topics of medical news and expert insight into IBD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBD and more.
October 20, 2025
Article
An audio recap of the top 5 stories in healthcare news from the week of 10/12-18.
October 13, 2025
The decision updates the indication statements for ulcerative colitis and Crohn’s disease to allow use in patients who have received ≥ 1 approved systemic therapy.
October 07, 2025
LUCENT-3 open-label extension study data establish mirikizumab-mrkz (Omvoh) as the first and only IL-23p19 to show sustained long-term outcomes in UC through 4 years.
October 06, 2025
The Q3 recap for gastroenterology spotlights key FDA decisions, new AGA gastroparesis guidelines, and other top GI news and research.
October 03, 2025
Read about new AGA gastroparesis guidelines, GI FDA news, and more.
September 26, 2025
Video
Rubin reflects on the FDA approval of a SC induction regimen for guselkumab (Tremfya) in UC and explains the significance of having both IV and SC induction options in IBD.
September 19, 2025
The approval offers the flexibility of self-administration from the start of treatment for UC, building on the prior approval of SC induction in Crohn’s disease.
September 16, 2025
Brogan discusses the various opportunities and challenges that have accompanied recent evolutions in inflammatory bowel disease management.
September 10, 2025
Brogan explains how to navigate the complexities of the Crohn’s disease treatment landscape and why patients need to be included in the decision making process.
August 01, 2025
From clinical trial updates in IBD to novel research about IBS and other disorders of gut brain interaction, catch up on the latest headlines in GI.